AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Osliglip-M500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Osiante Biotech

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Osliglip-M500 Tablet SR

Metformin and glimepiride, combined in Osliglip-M500 SR tablets, effectively manage elevated blood glucose in type 2 diabetes. This dual-action formulation mitigates the risk of severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack or stroke). Osliglip-M500 SR may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels prevents future complications. Continued commitment to your doctor's dietary and exercise plan is crucial. Lifestyle choices significantly influence diabetes management. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, and headache. Concurrent use with insulin or sulfonylureas increases hypoglycemia risk; learn to identify and manage low blood sugar. This medication isn't for everyone. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating individuals require medical consultation prior to use. Potential drug interactions necessitate disclosure of all medications to your doctor. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Uses of Osliglip-M500 Tablet SR

Managing Type 2 diabetes

Major Benefits of Osliglip-M500 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Osliglip-M500 SR tablets should be administered with a meal.

Common Side effects of Osliglip-M500 Tablet SR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Osliglip-M500 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Osliglip-M500 SR tablets with a meal.

How Osliglip-M500 Tablet SR works:

Metformin and glimepiride extended-release tablets, such as Osliglip-M500 SR, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Osliglip-M500 SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Osliglip-M500 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Osliglip-M500 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Osliglip-M500 Tablet SR on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should use Osliglip-M500 SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Osliglip-M500 SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Osliglip-M500 SR tablets; their use may be unsafe. Medical advice is recommended.

What if you forget to take Osliglip-M500 Tablet SR :

Should you forget to take your Osliglip-M500 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Osliglip-M500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Osliglip-M500 Tablet SR

Osliglip-M500 Tablet SR is safe when used as directed by your doctor. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Osliglip-M500 SR tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate calorie intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may occur, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Nausea and vomiting are possible side effects of Osliglip-M500 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Always consult your doctor before taking any other medication.
Osliglip-M500 SR tablets are contraindicated in patients allergic to any ingredient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Osliglip-M500 Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect characterized by elevated blood lactic acid. This risk is higher in patients with kidney disease, the elderly, and heavy alcohol users, thus metformin is avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Osliglip-M500 Tablet SR and seek immediate medical attention.
Prolonged Osliglip-M500 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). Report any of these symptoms to your doctor, who may recommend B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Osliglip-M500 Tablet SR
102
MRP 125
18% off